Clinical trial
Safety and Efficacy of SEBORRHEAMEDIS Face Cream in Patients With Seborrheic Dermatitis
NCT02656368 is registered in ClinicalTrials.gov with Kamedis Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety and Efficacy of SEBORRHEAMEDIS Face Cream in Patients With Seborrheic Dermatitis
- Lead sponsor
- Kamedis Ltd.
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- January 31, 2015
- Completion date
- December 31, 2015
- Enrollment
- 30 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
seborrheic dermatitis